Heart Disease Trial, Recruiting NCT07035106 Sponsor: Ludwig Boltzmann Gesellschaft Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07035106
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who were between 18 and 65 years old at the time they were admitted to an intensive care unit (ICU)
  • People who stayed in the ICU for at least 48 hours
  • People who have been discharged from the ICU within the last 2 years
  • People who have been diagnosed with diabetes and/or heart failure or coronary artery disease (a condition affecting the blood vessels of the heart)
  • People who are able to provide written consent to participate
  • People who have a home internet connection and a smartphone with internet and Bluetooth capability

Who may not be able to join:

  • People who have a legal guardian making decisions on their behalf
  • People without access to a smartphone or internet
  • People who have not been diagnosed with a cardiovascular (heart-related) disease or diabetes
  • People who have an implanted pacemaker or defibrillator
  • People who have known allergies to the materials used in the wearable devices used in this trial
  • People who were transferred from an ICU outside of the Medical University of Vienna
  • People who are currently experiencing homelessness
  • People who live outside of Austria

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Harald Willschke, Ao. Univ. Prof. Dr., Medical University of Vienna / Ludwig Boltzmann Institute for Digital Health and Patient Safety

Phone: +43 660 7432550

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ludwig Boltzmann Gesellschaft
Registry
ClinicalTrials.gov
Start date
1 July 2025
Est. completion
28 February 2026

Where this trial is recruiting

🇦🇹 Austria

Primary endpoints

Feasibility and Usability of Wearables in ICU Survivors

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov